Skip to main content
. 2024 Mar 27;14(7):3110–3124. doi: 10.1016/j.apsb.2024.03.021

Table 5.

Pharmacokinetic profiles of 15a·HCla.

Subject t1/2 (h) Tmax (h) Cmax (ng/mL) AUC0‒t (h·ng/mL) AUC0‒∞ (h·ng/mL) CL (mL/min/kg) F (%)
15a·HCl (iv)b 0.60 ± 0.03 0 ± 0.00 1785 ± 50.9 635 ± 9.85 640 ± 10.3 52.1 ± 0.82
15a·HCl (po)c 1.32 ± 0.13 2.00 ± 0.00 333 ± 58.3 1270 ± 307 1303 ± 322 40.8
a

PK parameters (mean ± SD, n = 3).

b

Dosed intravenously at 2 mg/kg.

c

Dosed orally at 10 mg/kg.